Relugolix trials for Prostate cancer
All Relugolix trials · All Prostate cancer trials
9
Recruiting trials
Phase breakdown
Phase 1 1Phase 2 6Phase 3 2
Recruiting trials studying Relugolix for Prostate cancer
- Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
- Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
- Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
- Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
- REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
- RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
- Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial
- Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
- Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Common questions
How many trials study Relugolix for Prostate cancer?
9 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.